Tekla Life Sciences Inves... (HQL)
12.29
-0.40 (-3.15%)
At close: Apr 01, 2025, 3:59 PM
-3.15% (1D)
| Bid | 12.25 |
| Market Cap | 336.14M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | 3.04 |
| PE Ratio (ttm) | 4.04 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 12.66 |
| Volume | 172,614 |
| Avg. Volume (20D) | 130,605 |
| Open | 12.65 |
| Previous Close | 12.69 |
| Day's Range | 12.25 - 12.66 |
| 52-Week Range | 12.25 - 15.90 |
| Beta | 0.72 |
About HQL
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries,...
Industry Asset Management
Sector Financial Services
IPO Date May 1, 1992
Employees NaN
Stock Exchange NYSE
Ticker Symbol HQL
